{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:59:26Z","timestamp":1781287166538,"version":"3.54.1"},"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure with preserved ejection fraction (HFpEF) is common in older multimorbid patients and is associated with substantial morbidity and mortality. Pacemaker (PM) patients may be particularly vulnerable given the clustering of conventional HFpEF risk factors and the hemodynamic effects of long-term right ventricular pacing. Nevertheless, HFpEF is rarely systematically assessed in device clinics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the prevalence of HFpEF in a cohort of permanent PM patients using a structured guideline-aligned screening protocol and to characterize their clinical, functional, and pacing-related profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PM-HFpEF is a single-center, prospective, cross-sectional study conducted at a tertiary hospital in Portugal. Eligible adults with conventional transvenous pacemakers and right ventricular apical pacing implanted between January 2018 and December 2022 will be invited to attend a one-day screening visit. The protocol includes clinical assessment, N-terminal pro-B-type natriuretic peptide testing, 12-lead electrocardiography, comprehensive transthoracic echocardiography, routine device interrogation, frailty assessment (the Portuguese-validated version of the Edmonton Frail Scale), and health-related quality-of-life evaluation using the 12-item Kansas City Cardiomyopathy Questionnaire. Exercise diastolic stress echocardiography using an upper-limb ergometer will be performed when resting findings are inconclusive. HFpEF will be adjudicated according to the 2021 European Society of Cardiology diagnostic definition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The PM-HFpEF study is designed to provide robust estimates of HFpEF prevalence within a real-world PM population, together with detailed characterization of their clinical and device-related profiles. This information may help inform future clinical assessment and research strategies for this often-overlooked yet clinically significant group of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0349667","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:45:58Z","timestamp":1781286358000},"page":"e0349667","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening for HFpEF in pacemaker patients: Study design and protocol of the PM-HFpEF study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6863-7890","authenticated-orcid":true,"given":"Elisabeth","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Primo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-5852","authenticated-orcid":true,"given":"Ant\u00f3nio","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Vilela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Fontes","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"pone.0349667.ref001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC","volume":"42","author":"TA McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"17","key":"pone.0349667.ref002","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"G Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"pone.0349667.ref003","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2022.06","article-title":"Epidemiology and clinical features of heart failure with preserved ejection fraction","volume":"8","author":"K Teramoto","year":"2022","journal-title":"Card Fail Rev"},{"key":"pone.0349667.ref004","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure","volume":"128","author":"VL Roger","year":"2021","journal-title":"Circ Res"},{"issue":"2","key":"pone.0349667.ref005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10741-024-10382-1","article-title":"Anti-bradycardia pacing-impact on patients with HFpEF: a systematic review","volume":"29","author":"A Ababei","year":"2024","journal-title":"Heart Fail Rev"},{"issue":"5","key":"pone.0349667.ref006","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jchf.2018.12.006","article-title":"Prior pacemaker implantation and clinical outcomes in patients with heart failure and preserved ejection fraction","volume":"7","author":"L Shen","year":"2019","journal-title":"JACC Heart Fail"},{"key":"pone.0349667.ref007","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf085.565","article-title":"The unrecognized burden of HFpEF in pacemaker patients: results from a systematic heart failure program","volume":"27","author":"E Santos","year":"2025","journal-title":"Europace"},{"issue":"9","key":"pone.0349667.ref008","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00392-024-02396-4","article-title":"Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment","volume":"113","author":"S von Haehling","year":"2024","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"pone.0349667.ref009","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCEP.108.814608","article-title":"Acute effects of right ventricular apical pacing on left ventricular synchrony and mechanics","volume":"2","author":"V Delgado","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"pone.0349667.ref010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tcm.2021.10.013","article-title":"Adverse effects of right ventricular pacing on cardiac function: prevalence, prevention and treatment with physiologic pacing","volume":"33","author":"TZ Naqvi","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"23","key":"pone.0349667.ref011","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.3390\/jcm11236889","article-title":"Cardiomyopathy associated with right ventricular apical pacing-systematic review and meta-analysis","volume":"11","author":"A Osiecki","year":"2022","journal-title":"J Clin Med"},{"issue":"7","key":"pone.0349667.ref012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028613","article-title":"Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial","volume":"9","author":"MF Paton","year":"2019","journal-title":"BMJ Open"},{"key":"pone.0349667.ref013","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf784.1033","article-title":"Improving HFpEF diagnosis in pacemaker patients: a call for structured screening","volume":"46","author":"E Santos","year":"2025","journal-title":"European Heart J"},{"issue":"4","key":"pone.0349667.ref014","article-title":"PO-05-190 prevalence of heart failure with preserved ejection fraction among patients with a permanent pacemaker","volume":"22","author":"J Howie","year":"2025","journal-title":"Heart Rhythm"},{"issue":"1","key":"pone.0349667.ref015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032873","article-title":"Effects of continuous accelerated pacing on cardiac structure and function in patients with heart failure with preserved ejection fraction: insights from the mypace randomized clinical trial","volume":"13","author":"KJ Wahlberg","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"16","key":"pone.0349667.ref016","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"SD Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0349667.ref017","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"SD Solomon","year":"2022","journal-title":"N Engl J Med"},{"issue":"9386","key":"pone.0349667.ref018","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"S Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"15","key":"pone.0349667.ref019","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"B Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0349667.ref020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of cardiovascular imaging and the American society of echocardiography","volume":"30","author":"H Baumgartner","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"pone.0349667.ref021","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation","volume":"30","author":"WA Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"pone.0349667.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ejechocard\/jen303","article-title":"Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice","volume":"10","author":"H Baumgartner","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"pone.0349667.ref023","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2020.10.026","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"AK Cheung","year":"2021","journal-title":"Kidney Int"},{"key":"pone.0349667.ref024","doi-asserted-by":"crossref","first-page":"2300239","DOI":"10.1183\/13993003.00239-2023","article-title":"Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary","volume":"61","author":"A Agust\u00ed","year":"2023","journal-title":"Eur Respir J"},{"issue":"2","key":"pone.0349667.ref025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10741-021-10105-w","article-title":"Biomarkers for the diagnosis and management of heart failure","volume":"27","author":"V Castiglione","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"8","key":"pone.0349667.ref026","first-page":"256","article-title":"Biomarkers of HFpEF: natriuretic peptides, high-sensitivity troponins and beyond","volume":"9","author":"P Morfino","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1","key":"pone.0349667.ref027","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"RM Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"pone.0349667.ref028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"SF Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"pone.0349667.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"J-U Voigt","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"pone.0349667.ref030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ehjci\/jey042","article-title":"Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"19","author":"LP Badano","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"pone.0349667.ref031","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeab154","article-title":"Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging","volume":"23","author":"OA Smiseth","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"40","key":"pone.0349667.ref032","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"B Pieske","year":"2019","journal-title":"Eur Heart J"},{"issue":"12","key":"pone.0349667.ref033","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/ejhf.184","article-title":"A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU-FP7 MEDIA study group","volume":"16","author":"T Erdei","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"pone.0349667.ref034","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.167.2.211","article-title":"ATS\/ACCP statement on cardiopulmonary exercise testing","volume":"167","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"pone.0349667.ref035","first-page":"1006","article-title":"A Systematic review and meta-analysis comparing cardiopulmonary exercise test values obtained from the arm cycle and the leg cycle respectively in healthy adults","volume":"11","author":"RT Larsen","year":"2016","journal-title":"Int J Sports Phys Ther"},{"key":"pone.0349667.ref036","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/ejhf.2601","article-title":"Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy \u2013 A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology","volume":"24","author":"M Guazzi","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"pone.0349667.ref037","first-page":"377","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"GA Borg","year":"1982","journal-title":"Med Sci Sports Exerc"},{"issue":"26","key":"pone.0349667.ref038","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"PA McKee","year":"1971","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0349667.ref039","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction","volume":"138","author":"YNV Reddy","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"pone.0349667.ref040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCOUTCOMES.115.001958","article-title":"Development and validation of a short version of the kansas city cardiomyopathy questionnaire","volume":"8","author":"JA Spertus","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"pone.0349667.ref041","first-page":"162","article-title":"Validation of the Portuguese version of the Kansas City Cardiomyopathy Questionnaire-12","volume":"10","author":"MC Dos Reis","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"pone.0349667.ref042","first-page":"1556","article-title":"Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an EHRA consensus document","volume":"19","author":"B Gorenek","year":"2017","journal-title":"Europace"},{"key":"pone.0349667.ref043","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project","volume":"35","author":"G Boriani","year":"2014","journal-title":"Eur Heart J"},{"issue":"40","key":"pone.0349667.ref044","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"K Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"10","key":"pone.0349667.ref045","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jacc.2007.01.025","article-title":"Recommendations for the standardization and interpretation of the electrocardiogram: part II: electrocardiography diagnostic statement list a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology","volume":"49","author":"JW Mason","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"pone.0349667.ref046","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003264","article-title":"Which QT correction formulae to use for QT monitoring","volume":"5","author":"B Vandenberk","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"pone.0349667.ref047","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1540-8167.2006.00408.x","article-title":"QT interval: how to measure it and what is \u201cnormal\u201d","volume":"17","author":"I Goldenberg","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"pone.0349667.ref048","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ageing\/afl041","article-title":"Validity and reliability of the Edmonton frail scale","volume":"35","author":"DB Rolfson","year":"2006","journal-title":"Age Ageing"},{"issue":"4","key":"pone.0349667.ref049","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.repc.2022.03.009","article-title":"Reproducibility and validity of the Portuguese edmonton frail scale version in cardiac surgery patients","volume":"42","author":"L Castro M de","year":"2023","journal-title":"Rev Port Cardiol"},{"issue":"3","key":"pone.0349667.ref050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association","volume":"23","author":"B Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"23","key":"pone.0349667.ref051","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","article-title":"Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction","volume":"107","author":"MO Sweeney","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"pone.0349667.ref052","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.hrthm.2014.05.040","article-title":"Incidence and predictors of right ventricular pacing-induced cardiomyopathy","volume":"11","author":"S Khurshid","year":"2014","journal-title":"Heart Rhythm"},{"key":"pone.0349667.ref053","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jacc.2009.06.006","article-title":"The effects of right ventricular apical pacing on ventricular function and dyssynchrony","volume":"54","author":"LF Tops","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"pone.0349667.ref054","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction","volume":"81","author":"BA Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"pone.0349667.ref055","doi-asserted-by":"crossref","DOI":"10.1186\/s42444-022-00078-8","article-title":"Impact of diastolic dysfunction in patients with preserved ejection fraction undergoing permanent cardiac pacemaker placement","volume":"23","author":"HK Jeong","year":"2022","journal-title":"Int J Arrhythm"},{"issue":"3","key":"pone.0349667.ref056","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/europace\/eut343","article-title":"Characteristics of a large sample of candidates for permanent ventricular pacing included in the Biventricular Pacing for Atrio-ventricular Block to Prevent Cardiac Desynchronization Study (BioPace)","volume":"16","author":"RC Funck","year":"2014","journal-title":"Europace"},{"issue":"2","key":"pone.0349667.ref057","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.hrthm.2022.09.019","article-title":"Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management","volume":"20","author":"V Somma","year":"2023","journal-title":"Heart Rhythm"},{"issue":"7","key":"pone.0349667.ref058","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf124","article-title":"Arrhythmia care in ESC member countries: the 2025 ESC-EHRA atlas on heart rhythm disorders","volume":"27","author":"MM Farkowski","year":"2025","journal-title":"Europace"},{"issue":"35","key":"pone.0349667.ref059","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"M Glikson","year":"2021","journal-title":"Eur Heart J"},{"issue":"18","key":"pone.0349667.ref060","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"RE Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"pone.0349667.ref061","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jchf.2023.07.014","article-title":"Pharmacological treatments in heart failure with mildly reduced and preserved ejection fraction","volume":"12","author":"S Zafeiropoulos","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"3","key":"pone.0349667.ref062","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2025.06.013","article-title":"Finerenone and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: a propensity-matched analysis","volume":"86","author":"T Calcagno","year":"2025","journal-title":"J Cardiol"},{"issue":"3","key":"pone.0349667.ref063","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamacardio.2022.5320","article-title":"Effect of personalized accelerated pacing on quality of life, physical activity, and atrial fibrillation in patients with preclinical and overt heart failure with preserved ejection fraction: the myPACE randomized clinical trial","volume":"8","author":"M Infeld","year":"2023","journal-title":"JAMA Cardiol"},{"key":"pone.0349667.ref064","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0735-1097(21)01582-5","article-title":"Personalized pacing (mypace): a new paradigm for diastolic heart failure treatment","volume":"77","author":"M Infeld","year":"2021","journal-title":"JACC"},{"issue":"5","key":"pone.0349667.ref065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.hroo.2024.03.009","article-title":"Accelerated physiologic pacing in patients with heart failure with preserved ejection fraction: an argument in support of therapeutic heart rate modulation","volume":"5","author":"M Infeld","year":"2024","journal-title":"Heart Rhythm O2"},{"issue":"5","key":"pone.0349667.ref066","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2024.03.1230","article-title":"PO-04-041 physiologic accelerated pacing as a treatment for heart failure with preserved ejection fraction","volume":"21","author":"N Habel","year":"2024","journal-title":"Heart Rhythm"},{"issue":"3","key":"pone.0349667.ref067","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf029","article-title":"Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace)","volume":"27","author":"RC Funck","year":"2025","journal-title":"Europace"},{"key":"pone.0349667.ref068","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2017.12.020","article-title":"Permanent pacemaker use among patients with heart failure and preserved ejection fraction: findings from the acute decompensated heart failure national registry (ADHERE) National Registry","volume":"198","author":"P Khazanie","year":"2018","journal-title":"Am Heart J"},{"issue":"12","key":"pone.0349667.ref069","first-page":"4579","article-title":"Assessment of left ventricular asynchrony after permanent cardiac pacing by using speckle tracking echocardiography","volume":"87","author":"SM Teima","year":"2019","journal-title":"Med J Cairo Univ"},{"issue":"18","key":"pone.0349667.ref070","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.jacc.2017.02.055","article-title":"Tricuspid valve dysfunction following pacemaker or cardioverter-defibrillator implantation","volume":"69","author":"JD Chang","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"pone.0349667.ref071","doi-asserted-by":"crossref","DOI":"10.1002\/joa3.70088","article-title":"The HFA-PEFF score and outcomes in patients with sick sinus syndrome and preserved ejection fraction after pacemaker implantation","volume":"41","author":"H Sumiyoshi","year":"2025","journal-title":"J Arrhythm"},{"key":"pone.0349667.ref072","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf085.564","article-title":"Comparing diagnostic accuracy of HFA-PEFF score vs. ESC guidelines definition of heart failure with preserved ejection fraction: findings from a pacemaker systematic screening program","volume":"27","author":"E Santos","year":"2025","journal-title":"Europace"},{"key":"pone.0349667.ref073","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4250\/jcu.2011.19.4.169","article-title":"Use and limitations of E\/e\u2019 to assess left ventricular filling pressure by echocardiography","volume":"19","author":"JH Park","year":"2011","journal-title":"J Cardiovasc Ultrasound"},{"issue":"4","key":"pone.0349667.ref074","first-page":"558","article-title":"Validation of an arm crank ergometer test for use in sedentary adults","volume":"16","author":"A Mitropoulos","year":"2017","journal-title":"J Sports Sci Med"},{"key":"pone.0349667.ref075","doi-asserted-by":"crossref","DOI":"10.1249\/00005768-198910001-00003","article-title":"Cardiovascular responses to upper body exercise in normals and cardiac patients","volume":"21","author":"DS Miles","year":"1989","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"pone.0349667.ref076","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/ehjci\/jeac036","article-title":"Left atrial reservoir strain improves diagnostic accuracy of the 2016 ASE\/EACVI diastolic algorithm in patients with preserved left ventricular ejection fraction: insights from the KARUM haemodynamic database","volume":"23","author":"A Venkateshvaran","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"pone.0349667.ref077","first-page":"313","article-title":"Left atrial strain in patients with chronic heart failure with preserved ejection fraction: a narrative review","volume":"15","author":"DE Man","year":"2025","journal-title":"Life (Basel)"},{"issue":"6","key":"pone.0349667.ref078","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00392-018-1399-8","article-title":"Left atrial strain improves estimation of filling pressures in heart failure: a simultaneous echocardiographic and invasive haemodynamic study","volume":"108","author":"A Lundberg","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"23","key":"pone.0349667.ref079","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"BM Massie","year":"2008","journal-title":"N Engl J Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0349667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:46:10Z","timestamp":1781286370000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0349667"}},"subtitle":[],"editor":[{"given":"Amirmohammad","family":"Khalaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":79,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0349667","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}